What is BCMA cancer?

B cell maturation antigen (BCMA) is a novel treatment target for multiple myeloma (MM) due to its highly selective expression in malignant plasma cells (PCs).

What does CD138 positive mean?

CD138 is a classic plasma cell marker and can be found on both normal polyclonal or abnormal monoclonal plasma cells. Being CD138 positive and knowing the total plasma cell % from the core bone specimin would be the best markers to understand the extent of bone marrow infiltration.

What does CD138 stain?

CD138 is expressed on plasma cells and can be useful in the diagnosis of plasma cell neoplasms. Epithelial cells and endothelial cells may also express CD138. In normal tonsil tissue, CD138 strongly stains the membranes of mature plasma cells and squamous epithelial cells.

Why is CD38 important?

CD38 is a glycoprotein with ectoenzymatic functions, which is expressed on plasma cells and other lymphoid and myeloid cell populations. Since its expression is very high and uniform on myeloma cells, CD38 is a good target for novel therapeutic strategies. Among them, immunotherapy represents a promising approach.

What is CD38-positive?

Patients in the CD38-positive cohort were characterised by an unfavourable clinical course with a more advanced disease stage, poor responsiveness to chemotherapy, short time to initiation of first treatment and shorter survival.

Is BCMA secreted?

BCMA is shed during differentiation to Ig-secreting cells. Since mBCMA is known to be expressed on some activated B cells and Ig-secreting cells5,6, we analysed the release of sBCMA by primary human B cells.

What is BCMA multiple myeloma?

The field of myeloma treatment in refractory or relapsed patients after standard therapy entered a new era due to the B-cell maturation antigen (BMCA) targeted approach. BCMA is a member of the tumor necrosis factor receptor family with high expression in mature B-lymphocytes and plasma cells.

What is CD138 Immunostain?

The transmembrane heparin sulfate proteoglycan syndecan-1 (CD138) is a syndecan, which is a specific marker of plasma cells. Therefore, in current clinical practice, CD138 immunohistochemistry is used for the detection of chronic endometritis to improve its diagnosis rate [11].

What is Kappa Lambda?

Light chains are proteins produced by immune cells called plasma cells. Also called kappa and lambda light chains, they link together with other proteins (heavy chains) to form immunoglobulins (also known as antibodies) that target and neutralize specific threats to the body such as bacteria and viruses.

Is multiple myeloma benign or malignant?

Multiple myeloma is a malignant proliferation of plasma cells that involves more than 10 percent of the bone marrow.

What is CD38 negative?

Comparison of CD38+ and CD38− patient subgroups Patients with 20% or more B cells expressing CD38 were considered positive, and those with less than 20% were considered negative.

How do you stop CD38?

Flavonoids. Several naturally occurring compounds are reported to inhibit the catalytic activity of CD38 including flavonoid compounds apigenin, quercetin, and leteolinidin (8, 102, 107) (Table 1).

Why is BCMA important?

BCMA systems reduce medication errors by electronically verifying the ‘5 rights’ of medication administration—right patient, right dose, right drug, right time, right route—at the patient’s bedside.

What type of protein is BCMA?

BCMA is an Important Surface Protein Supporting the Survival of MM Cells. B cell maturation antigen, also termed tumor necrosis factor receptor superfamily member 17 (TNFRS17), is a type III transmembrane protein without a signal-peptide and containing cysteine-rich extracellular domains (43–45).

What is BCMA targeted therapy?

BCMA-targeted agents are an exciting new treatment approach for patients with relapsed/refractory (R/R) MM. BCMA stands for B‑cell maturation antigen, which is a protein that is expressed on late-stage B-cells, plasma cells, and plasmablasts.

What is Monotypic Kappa?

Plasma cell populations with a kappa to lambda ratio of either greater than 3.9 or less than 0.5 will be considered either kappa or lambda immunoglobulin light chain restricted (monotypic), respectively.

Is death from multiple myeloma painful?

Accounts of those who have accompanied a loved one as they died from complications of multiple myeloma generally report a relatively calm death in which pain has been effectively managed.

Who is Samir Patel?

Specializing in the use of cutting-edge technologies for the treatment of chronic pain, Dr. Samir Patel is a Dual Board Certified in Anesthesiology and Pain Management physician treating patients with an evidence based and multidisciplinary approach that restores the patient’s quality of life and functionality.

Who is Dr Priti Patel?

His professional interests include, but are not limited to Complex Regional Pain Syndrome, acute and chronic back and neck pain, Cancer related pain, pain sustained from injuries from motor vehicle accidents and other refractory painful conditions. Dr. Patel is originally from Nairobi, Kenya.

Where did Dr Patel go to college?

Dr. Patel is originally from Nairobi, Kenya. He moved to Texas for college and attended the University of Texas at Arlington, where he graduated Magna Cum Laude. He then attended the Texas College of Osteopathic Medicine, where he learned to embrace a holistic approach to medicine early in his career.